DNA diagnostics, the detection of specific DNA sequences, will play an increasingly important role in medicine as the molecular basis of human disease is defined. Here, we demonstrate an automated, nonisotopic strategy for DNA diagnostics using amplification of target DNA segments by the polymerase chain reaction (PCR) and the discrimination of allelic sequence variants by a colorimetric oligonucleotide ligation assay (OLA). We have applied the automated PCR/OLA procedure to diagnosis ofcommon genetic diseases, such as sickle cell anemia and cystic fibrosis (AF508 mutation), and to genetic linkage mapping of gene segments in the human T-cell receptor f-chain locus. The automated PCR/OLA strategy provides a rapid system for diagnosis of genetic, malignant, and infectious diseases as well as a powerful approach to genetic linkage mapping of chromosomes and forensic DNA typing.
The study of DNA sequence variants in humans is playing an important role in diagnosis of genetic and malignant diseases (1, 2) . The analysis of DNA polymorphisms also serves as the fundamental tool in attempts to construct genetic linkage maps (3, 4) and in forensic analyses (5, 6) . Since the majority of DNA sequence variants and polymorphisms are single nucleotide substitutions (1, 2) , diagnostic techniques must accurately discriminate single base changes.
Single base variations in DNA sequences can be detected by a variety of techniques including Southern blot analysis (7) for restriction fragment length polymorphisms, allele-specific oligonucleotide hybridization (8) , denaturing gradient gel electrophoresis (9) , chemical cleavage of mismatched heteroduplexes (10) , conformational changes in single strands (11) , and allele-specific priming of the polymerase chain reaction (PCR) (12) (13) (14) . These techniques have several disadvantages for automating DNA diagnosis, which include the use of radioactivity, the requirement for various hybridization conditions, and the need for electrophoresis or centrifugation.
The analysis of DNA sequence variants has been greatly facilitated by the development of rapid methods to exponentially amplify specific DNA or RNA targets. Diagnostic targets can be amplified by PCR (15) (16) (17) or by other available methods (18) (19) (20) (21) . Amplification generates specific targets with high signal/noise ratios and permits the use of less sensitive nonisotopic reporters in DNA analysis.
An alternative strategy for DNA diagnosis, the oligonucleotide ligation assay (OLA), employs two adjacent oligonucleotides (20-mers), a 5' biotinylated probe (with its 3' end at the nucleotide to be assayed) and a 3' reporter probe (22) (23) (24) . The two oligonucleotides are hybridized to target DNA and, if there is perfect complementarity, the enzyme DNA ligase covalently joins the 5' biotinylated probe and the 3' reporter probe. If the probes and target are mismatched at their junction, a covalent bond is not formed. Capture of the 5' biotinylated probe on immobilized streptavidin and analysis for covalently linked 3' reporters determine the nature of the probe-target interaction (matched or mismatched). The ligase assay uses a standard set ofconditions to distinguish all nucleotide mismatches, and product analysis does not require electrophoresis or centrifugation (22) . In this report, we describe a strategy for automating DNA diagnosis that combines target amplification by PCR with a nonisotopic analysis of DNA sequence variants by OLA.
MATERIALS AND METHODS
Robotic Workstation. A Biomek 1000 workstation (Beckman) equipped with multipipet tools and a multibulk tool was used to perform all pipetting, aspirating, and washing procedures. The workstation has been modified with a solenoid to switch wash solutions during the ELISA. All reagents for sample processing were stored in sterile 96-minitube cassettes.
DNA Samples. DNA from humans with a1-antitrypsin, ,8-globin, and cystic fibrosis variants was obtained from F. Heijtmancik (Baylor University), from K. Tanaka (Harbor Hospital) and J. Korenberg (Cedar-Sinai Hospital), and from A. Osher and E. Hsu (Children's Hospital), respectively, and prepared as described (22) . DNA for amplification of human T-cell receptor 1-chain (TCR/3) gene segments was obtained by gently scraping cells from the lining of the buccal cavity with a sterile toothpick. Buccal cells were dislodged into a minitube containing 10 A.l of sterile H20, covered with 75 A.l of mineral oil, and placed into a 96-minitube cassette for handling by the robotic workstation. Cells were lysed with 20 p.1 of 0.1 M KOH and 0.1% Triton X-100 at 65°C for 20 min and neutralized with 20 ,ul of 0.1 M HCl and 0.1% Triton X-100.
Oligonucleotides. Amplification primers and ligation probes were assembled by using standard phosphoramidite chemistry on an Applied Biosystems 380A DNA synthesizer. Ligation probes were modified with a 5' biotin group as described (15) 
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Proc. Natl. Acad. Sci. USA 87 (1990) (25) . The probability of linkage disequilibrium was calculated based on the x2 distribution of the Q statistic described by Hedrick et al. (26) . RESULTS The Automated PCR/OLA Strategy. Our strategy for automated gene analysis is shown in Fig. 1 . A Biomek 1000 robotic workstation was used to (i) prepare targets and assemble reagents for DNA amplification, (ii) mix and ligate 5' biotinylated probes and 3' digoxigenin-labeled reporter probes on amplified DNA targets using T4 DNA ligase, (iii) capture 5' biotinylated probes on streptavidin-coated microtiter plates, (iv) wash plates, and (v) detect the digoxigenin reporter coupled to biotin-labeled probes by an ELISA. Altogether, processing time for 96 samples from entry to computer read-out takes <7 hr. Overnight amplification permits processing of ligation assays from 192 DNA samples in a single day (1200 reactions, triplicates for two alleles).
Amplification Primers and Ligation Probes. A panel of amplification primers and ligation probes for known sequence variants in human DNA have been synthesized (Table  1) . Two sets of probes detect mutations that cause common genetic diseases in homozygous individuals, sickle cell anemia and CF (27, 28) . Another set detects a common mutation in the a1-antitrypsin gene that, in homozygous individuals, leads to a predisposition for cirrhosis of the liver in childhood and emphysema in adults (29) . The remaining probes detect Genetics: Nickerson et al. (Table 1) were present in each of the amplified samples (Fig. 2 ). Fig. 3 Amplified DNA targets obtained from genomic DNA samples were analyzed in triplicate by using the indicated combinations of ligation probes (alleles 1 and 2 as described in Table 1 ) for each specified gene segment. Wells containing digoxigenin form a magenta-colored product and indicate complementarity between the ligation probes and amplified DNA target. gest that hot spots of recombination exist in the TCRj3 locus (34) . DISCUSSION Automated analysis of DNA polymorphisms and variants by PCR/OLA has many advantages over existing approaches to DNA diagnostics. Small numbers of cells (cheek scraping) or DNA samples (10 ng) are sufficient for analysis. Only small fragments of DNA (a few hundred base pairs) are required. Therefore, partially degraded DNA is still useful. The reagents are stable and easily obtained, and nonisotopic reporter groups are used. The entire assay is performed in microtiter wells, thus avoiding the use of centrifugation or electrophoresis. The assay yields high signal/noise ratios and a simple readout that is easily transferred to a computer for storage and analysis; no measurements of DNA fragment sizes are necessary. All of the tested sequence variants (nucleotide transitions and transversions, and a deletion) could be discriminated by OLA using a standard set of conditions. The initial PCR amplification facilitates the discrimination of polymorphisms in individual members of a multigene family (e.g., the TCR V136.7 gene segment is one of 13 8. 4 13 13 Gentomee. nine highly similar members of the V,06 subfamily). The two successive levels of sequence discrimination, PCR and then OLA, enhance signal/noise ratios and reduce the likelihood of error, particularly in the analysis of polymorphisms in multigene families. The steps in the assay are automatable, eliminating the need for human intervention (and possible mistakes) in a tedious and repetitious process. With automation, high throughput is possible. At present, we can process 1200 ligation reactions per day with a single operator and robotic workstation, and, in the near future, further automation with a robotic arm will permit processing of 6000 reactions per day.
The automated PCR/OLA assay can be applied in many different basic research and clinical areas. Genetic diseases fall into several different categories including the common and widespread mutations of sickle cell disease, a,-antitrypsin or CF, and newly arising spontaneous mutations such as Lesch-Nyhan disease (35) . Clearly, PCR/OLA facilitates the analysis of the common mutations, either in screening at-risk members of families with diseases or for more general carrier screening purposes. Rapid techniques are being developed to identify the sequence variations of newly arising mutations (35, 36) . Once identified, the combined PCR/OLA procedure can be used to follow the inheritance of these specific mutations in affected families. Many genes cause a predisposition toward disease. This is true of the a1-antitrypsin mutation described above. Recently, it has been demonstrated that certain TCR and HLA haplotypes may predispose humans to certain autoimmune diseases such as multiple sclerosis (37) (38) (39) . Therapeutic strategies are being developed to circumvent these predispositions (40) (41) (42) 
